Pharmabiz

Roche’s Gazyva/Gazyvaro receives US FDA approval for the treatment of lupus nephritis

Roche’s Gazyva/Gazyvaro receives US FDA approval for the treatment of lupus nephritis: Basel Wednesday, October 22, 2025, 10:00 Hrs [IST] Roche announced that the US Food and Dr ...
Pharmabiz

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose

Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose: Paris Wednesday, October 22, 2025, 09:00 Hrs [IS ...
Pharmabiz

Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt contamination: TN IDMA

Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt contamination: TN IDMA: Peethaambaran Kunnathoor, Chennai Wednesday, October 22, 2025, 08:00 H ...
Pharmabiz

Health ministry to mandate tracking mechanism for vaccines, antimicrobials, cancer and N&P drugs

Health ministry to mandate tracking mechanism for vaccines, antimicrobials, cancer and N&P drugs: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] The Union mi ...
Pharmabiz

Govt discusses challenges faced by exporters during import, export clearance of temperature sensitive consignments

Govt discusses challenges faced by exporters during import, export clearance of temperature sensitive consignments: Shardul Nautiyal, Mumbai Wednesday, October 22, 2025, 08:00 Hrs ...
Pharmabiz

Health ministry issues draft amendment to move preparations with higher alcoholic content under Schedule H1

The Union health ministry has proposed an amendment to the Schedule K of the Drugs Rules, 1945, to move all oral formulations with higher alcoholic content more than 30 ml to Schedule H1 for enhanced ...
Pharmabiz

Centre to amend Drugs Rules related to licensing of stem cell derived & gene therapy products

Centre to amend Drugs Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] The Union minis ...
Pharmabiz

MITM IPA-Mysuru Local Branch, JSS Pharmacy College, Mysuru & others note importance of Healthy Women –Healthy Society

MITM IPA-Mysuru Local Branch, JSS Pharmacy College, Mysuru & others note importance of Healthy Women –Healthy Society: Our ...
Pharmabiz

Boehringer Ingelheim’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC

Boehringer Ingelheim’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC: Ingelheim, Germany Monday, Oc ...
Pharmabiz

Tolremo therapeutics completes first in human dose escalation for TT125-802 and presents solid tumour monotherapy results at ESMO 2025

Tolremo therapeutics completes first in human dose escalation for TT125-802 and presents solid tumour monotherapy results at ESMO 2025: Basel Monday, October 20, 2025, 15:30 Hrs [ ...
Pharmabiz

Renalys Pharma reaches Japan PMDA agreement on phase III trials of sparsentan for FSGS and Alport syndrome

Renalys Pharma reaches Japan PMDA agreement on phase III trials of sparsentan for FSGS and Alport syndrome: Tokyo, Japan Monday, October 20, 2025, 18:00 Hrs [IST] Renalys Pharma, ...
Pharmabiz

Keytruda plus Lenvima demonstrates durable 5-year survival benefit versus chemotherapy for patients with advanced endometrial carcinoma following one prior platinum-based regimen

Keytruda plus Lenvima demonstrates durable 5-year survival benefit versus chemotherapy for patients with advanced endometrial carcinoma following one prior platinum-based regimen: ...